b'$ 3 , 1 1 7 , 9 8 5 R A I S E DSTATEMENT OF FINANCIAL POSITIONWHERE OUR DOLLARS 202220212020 WENT IN 2022ASSETS G&A Expenses$137,0423.3%Current AssetsCash and investments$2,336,241 $3,125,675$2,982,807 Receivables 153,450 161,432 39,662Fundraising$756,532Prepaid expenses188,717 89,74299,73218.1%Total Current Assets 2,678,408 3,376,849 3,122,201 Pediatric Cancer ResearchProperty and Other Assets 602,797250,55811,803$3,294,09478.6%TOTAL ASSETS$3,281,205$3,627,407 $3,134,004 In 2022, PCRF saw an increase in revenues with theLIABILITIES & NET ASSETS return of in-person events, the addition of three new G&A ExpensesDribble events and the 7th Annual International $137,042Symposium on Childhood, Adolesce 3.3%Current Liabilitiesnt and Young Adult Non-Hodgkin Lymphoma.Accounts payable$ 183,556$ 68,072$ 25,199Due to the pandemic, PCRF did not fund any Grants Payable1,068,726 895,784295,571new grants in 2021. In 2022, PCRF increased its Deferred Revenue186,35546,58335,034institutional grants by $450,000. Fundraising$756,532PCRF continued its strategic investment in fundraising PPP Loan Advance82,933platforms, staffing and marketing in 2022. 18%Operating Lease Liability378,216 Total Current Liabilities1,816,8531,093,372355,804 RESERVES BALANCENET ASSETS $3,233,755$3,117,985$3,026,559 $2,961,905Unrestricted net assets1,464,3522,534,0352,778,200 $2,912,597 $2,821,956TOTAL LIABILITIES& NET ASSETS $3,281,205$3,627,407$3,134,0042017 2018 2018 2020 2021 202219'